Corning and Microinnova Celebrate Opening of Advanced-Flow™ Reactor Qualified Lab
Corning Incorporated and Microinnova recently celebrated the opening of the Corning® Advanced-Flow™ Reactors (AFR) Application Qualified Lab (AQL) at their facility near Graz. Application qualified labs enable AFR customers to effectively access continuous-flow demonstrations, experimental trials, feasibility testing, and chemical reaction process development.
Corning currently has one other AQL in Europe at the University of Liège, which opened in 2017, as well as several operational AQLs worldwide that support the business. These regional facilities provide customers with convenient access to AFR Technology.
Microinnova is an innovation-based company focused on process development, design, and the realization of continuous pilot lines and manufacturing plants. Based on their critical parameter approach, Microinnova intensifies synthesis, as well as work-up and formulation processes using a wide range of different technologies leading to high-performance processes.
Microinnova has recently established a fluorine lab at their facility in Graz and are utilizing Corning’s G1 Silicon Carbide (G1 SiC) reactors to process highly toxic and corrosive chemicals in an inherently safer, more efficient way that can help customers in pharmaceutical, fine and specialty chemicals industries create a better end product.
“We’ve worked closely with Microinnova over the last few years, and the core values of innovation and commitment to inherently safer continuous flow chemistry really makes this collaboration a great fit for both companies,” said Alessandra Vizza, regional business director, Corning® Advanced-Flow Reactors. “Corning’s equipment and materials enable more stable reactions and can reduce inherent risks associated with handling/processing hazardous chemicals – which is really what the core of AFR Technology is all about.”
The location of this laboratory will help Microinnova provide broader reach to their customer base within the pharmaceutical, fine and specialty chemicals industries in Europe.
“We operate to strengthen our capabilities in the fields of fast, exothermic or highly corrosive processes for development as well as for manufacturing plant realization as a system integrator,” said Dr. Dirk Kirschneck, strategic director, Microinnova. “Based on the strong collaboration between the two companies since 2007, we are looking forward to continuing to work with Corning on future programs as one of their Application Qualified Labs.”
In addition to its AQLs, a critical part of the AFR business’ model for more than a decade has been its commitment to educating the regions where it operates.
“In Europe, we’re actively trying to educate both at the academic and industrial level on the value of continuous flow technology,” Alessandra said. “We’re hopeful that our broad product offerings as well as collaborations with companies like Microinnova will help us in this effort.”
Related News
-
Sponsored Content CPHI Online Trend Report: How can flow chemistry help businesses achieve their sustainability goals?
In our latest CPHI Online Trend Report, we partner with Asymchem to understand the innovative potential of flow chemistry for API manufacturing, especially in regards to meeting sustainability goals. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
Sponsored Content Discover Our Organic Mineral Salts as APIs
Discover the range of organic mineral salts that serve as Active Pharmaceutical Ingredients available from Dr. Paul Lohmann®. -
Sponsored Content CPHI Podcast Series: Ursatec – celebrating 30 years of pioneering preservative free
In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec. -
Sponsored Content How healthcare trends inform dosage forms
Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op... -
Sponsored Content Pharma Trend Outlook: Pharma 4.0 and Industry Resilience
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner
In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection. -
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&A
Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance